Patient and physician outcry resulted in FDA overturning its rejection of a MS drug. Could the same thing happen with chronic fatigue syndrome and Ampligen?
Into the Big Leagues Low dose naltrexone (LDN) is able to do for some people with intractable pain what opioids and other drugs can’t do – reduce the pain. Those drugs have something LDN doesn’t, however, – FDA approval. You can’t prove that LDN works,...
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.